Trial Profile
An observer-blind,randomized study of meningococcal B vaccines (4CMenB) in adolescents and young adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Dec 2016
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group B (Primary)
- Indications Meningococcal group B infections
- Focus Adverse reactions
- 27 Dec 2016 New trial record
- 30 Oct 2016 Results presented at the IDWeek 2016.